GoodRx Holdings, Inc. — Form 8-K
Filed November 2, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
GoodRx filed Form 8-K on November 2, 2026, disclosing Item 4.02—non-reliance on previously issued financial statements or audit reports. The filing indicates a restatement of financial results, though the specific dollar amounts, affected periods, nature of errors, and remediation steps are not detailed in this document header. The company's management indicated it cannot rely on prior financial statements or audit reports as of October 27, 2026.
Why this rating
Restatement signals control/audit failures material to investor confidence; relative to $423M market cap, restated results could be significant. Specifics needed.
Extracted items
- 4.02 non-reliance / restatement
Price action (we called it negative)
before filing · preread $3.55 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.